dihydroxyphenylalanine has been researched along with Age-Related Macular Degeneration in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smoliakova, GP | 1 |
| Rodivoz, MI | 1 |
1 other study available for dihydroxyphenylalanine and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Evaluation of the therapeutic action of DOPA and phosphaden in experimental dystrophic changes of the retina induced by disorders of the functional state of the sympatho-adrenal system].
Topics: Adenosine Monophosphate; Adrenal Medulla; Animals; Dihydroxyphenylalanine; Drug Evaluation, Preclini | 1988 |